ICLRICON Public Limited Company

NAS · US · Healthcare · Diagnostics & Research · iconplc.com

172.23USDMkt Cap: 13.29B $P/E: 269.113d ago

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the str…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

$44.91BUSDP/E 31.9

IDXX

IDEXX Laboratories, Inc.

Mettler-Toledo International, Inc.

$27.96BUSDP/E 31.5

Labcorp Holdings Inc.

$27.28BUSDP/E 27.8

DGX

Quest Diagnostics Incorporated

$26.97BUSDP/E 26.0

Guardant Health, Inc.

$22.91BUSD

MEDP

Medpace Holdings, Inc.

$17.33BUSDP/E 36.4

ERF

Eurofins Scientific SE

$13.65BUSDP/E 25.3

CRL

Charles River Laboratories International, Inc.

$14.09BUSD

RVTY

Revvity Inc. Common Stock

Twist Bioscience Corp.

Key Statistics

Company

Market Cap13.29B $

Enterprise Value16.05B $

Revenue (TTM)8.29B $

Gross Profit2.18B $

Net Income (TTM)229.34M $

Revenue/Share107.96 USD

Last Price172.23 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees40.2K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISINIE0005711209

Valuation

P/E (Trailing)269.11

P/E (Forward)14.67

PEG0.56

EV/EBITDA30.66

EV/Revenue1.94

P/S1.62

P/B1.43

EPS (TTM)0.66

EPS (Forward)11.88

52W Range

172.053% of range179.02

52W High179.02 USD

52W Low172.05 USD

Profitability

Gross Margin26.37%

Oper. Margin9.41%

EBITDA Margin6.31%

Profit Margin2.78%

ROE2.49%

ROA1.41%

Growth

Revenue Growth1.20%

Earnings Growth-63.30%

Cash Flow & Leverage

Operating CF1.04B $

CapEx (TTM)174.21M $

FCF Margin7.51%

FCF Yield4.69%

Net Debt2.60B $

Net Debt/EBITDA4.96

Balance Sheet

Debt/Equity0.39

Current Ratio0.95

Quick Ratio0.92

Book Value/Sh121.55 USD

Cash/Share12.03 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split2:1

Split DateAug 13, 2008

Analyst Consensus

Rating1.9 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)185.56 USD

Upside (mean)+7.7%

Target Range155.00 USD – 220.00 USD

$155.00+7.7% to mean$220.00

# Analysts16

Ownership

Shares Out.77.15M

Float77.10M

Insiders0.44%

Institutions108.37%

Short Interest

Short Ratio2.7d

Short % Float3.26%

Short % Out.2.88%

Shares Short2.22M

Short (prev mo.)2.99M

Technical

SMA 50163.27 (+5.5%)

SMA 200147.11 (+17.1%)

Beta1.20

S&P 52W Chg21.00%

Avg Vol (30d)389.16K

Avg Vol (10d)535.93K

Technical Indicators

RSI (14)56.7

MACD2.0963

MACD Signal1.5586

MACD Hist.+0.5376

BB Upper179.24 USD

BB Middle167.28 USD

BB Lower155.32 USD

BB Width14.30%

ATR (14)7.645 USD

Vol Ratio (20d)0.48x